Pardes Biosciences downgraded by JMP Securities
$PRDS
Medicinal Chemicals and Botanical Products
Health Care
JMP Securities downgraded Pardes Biosciences from Mkt Outperform to Mkt Perform
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/18/2023 | Mkt Outperform → Mkt Perform | JMP Securities | |
| 3/15/2022 | Outperform | SVB Leerink | |
| 1/18/2022 | $25.00 | Buy | Jefferies |